Cookie Policy

Mereo BioPharma Group plc's website uses cookies. By continuing to browse you are agreeing to our use of cookies. Find out more about our Cookie Policy.

MREO: US$2.51 MPH: 36.00GBp
Mereo-Banner-Image.jpg

Working together to inspire, innovate and improve lives

See our latest news

News

11 Nov 2019 Mereo BioPharma Phase 2b ASTEROID Study
7 Oct 2019 FDA Fast Track Designation for Navicixizumab
17 Sep 2019 Interim Financial Results for the Six Months Ended June 30, 2019 and Corporate Update
Press Releases

View our latest Corporate Presentation

section-img.jpg
24 OCT 2019 Corporate presentation
11 NOV 2019 Mereo BioPharma Phase 2b ASTEROID Study - Today 8.00 AM ET / 13.00 PM GMT Conference call
profile-img.jpg
quote.svg

We continue to make strong progress in development of our product portfolio, in the hope of providing better treatment options for patients suffering from rare diseases

Denise Scots-Knight, CEO Our Mission